In this video, Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, briefly discusses the role of navtemadlin in the treatment of myeloproliferative neoplasms (MPNs) and the mechanism of action of this agent. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

свернуть